
Lexicon Pharmaceuticals Inc (LXRX)
NASDAQ
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -28.295 | -33.454 | 37.083 | -18.849 | -51.517 | -61.559 | -83.6 | -75.932 |
Return on Equity (%) | -123.196 | -938.226 | 286.965 | -42.837 | -65.014 | -88.371 | -168.497 | -167.659 |
Return on Invested Capital (%) | -51.463 | -40.555 | 60.472 | -70.437 | -64.519 | -72.152 | -96.086 | -90.076 |
Operating Margin (%) | -149.142 | -157.843 | 44.957 | -183.497 | -29179.866 | -71341.007 | -13622.757 | -594.653 |
Net Profit Margin (%) | -142.857 | -190.713 | 40.405 | -244.109 | -29448.993 | -73341.007 | -14710.88 | -644.777 |
Book Value Per Share | -0.42 | -1.143 | 0.497 | 0.79 | 0.464 | 0.385 | 0.198 | 0.281 |
Earnings Per Share | -1.222 | -1.138 | 1.225 | -0.414 | -0.589 | -0.54 | -0.723 | -0.554 |
Cash Per Share | 0.584 | 0.759 | 0.34 | 0.892 | 0.43 | 0.246 | 0.092 | 0.184 |
Working Capital Per Share | 1.874 | 1.289 | 2.563 | 0.784 | 0.449 | 0.624 | 0.592 | 0.556 |
Operating Profit Per Share | 0.852 | 0.59 | 3.017 | 0.156 | 0.002 | 0.001 | 0.005 | 0.084 |
EBIT Per Share | -1.342 | -1.138 | 1.168 | -0.414 | -0.589 | -0.54 | -0.723 | -0.554 |
EBITDA Per Share | -1.342 | -1.138 | 1.168 | -0.414 | -0.589 | -0.54 | -0.723 | -0.554 |
Free Cash Flow Per Share | -1.252 | -1.172 | 1.191 | -0.434 | -0.583 | -0.535 | -0.723 | -0.553 |
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 105.59M | 105.93M | 106.27M | 141.5M | 148.92M | 188.73M | N/A | N/A |
Year End December 30 2024 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -125470.833 | N/A | N/A | N/A | -3845.044 | N/A | N/A | N/A |
Net Profit Margin (%) | -133058.333 | N/A | N/A | N/A | -4282.92 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 180.75M |
Price to Earnings Ratio | -0.92 |
Price to Sales Ratio | 5.93 |
Price to Cash Ratio | 2.77 |
Price to Book Ratio | 1.26 |
Dividend Yield | - |
Shares Outstanding | 361.49M |
Average Volume (1 week) | 5.65M |
Average Volume (1 Month) | 32.07M |
52 Week Change | -70.23% |
52 Week High | 2.45 |
52 Week Low | 0.2836 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.